A U.S. federal judge rejected Swiss drugmaker Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Novartis could soon face generic competition for Entresto after judge's ruling.

Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

“Generic medications are not an exact carbon copy of the name-brand counterpart, but they are very close,” Sevilla says. The main differences involve what inactive ingredients they contain.